BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 17439909)

  • 1. Coping and quality of life in one hundred and thirty five subjects with multiple sclerosis.
    Montel SR; Bungener C
    Mult Scler; 2007 Apr; 13(3):393-401. PubMed ID: 17439909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coping and quality of life of patients with Parkinson disease who have undergone deep brain stimulation of the subthalamic nucleus.
    Montel SR; Bungener C
    Surg Neurol; 2009 Aug; 72(2):105-10; discussion 110-1. PubMed ID: 18786708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in relation to mood, coping strategies, and dyskinesia in Parkinson's disease.
    Montel S; Bonnet AM; Bungener C
    J Geriatr Psychiatry Neurol; 2009 Jun; 22(2):95-102. PubMed ID: 19150974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social anxiety in a multiple sclerosis clinic population.
    Poder K; Ghatavi K; Fisk JD; Campbell TL; Kisely S; Sarty I; Stadnyk K; Bhan V
    Mult Scler; 2009 Mar; 15(3):393-8. PubMed ID: 19028833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of quality of life among patients with multiple sclerosis: an Italian cross-sectional study.
    Patti F; Russo P; Pappalardo A; Macchia F; Civalleri L; Paolillo A;
    J Neurol Sci; 2007 Jan; 252(2):121-9. PubMed ID: 17188301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of cognitive impairment on coping strategies in multiple sclerosis.
    Goretti B; Portaccio E; Zipoli V; Hakiki B; Siracusa G; Sorbi S; Amato MP
    Clin Neurol Neurosurg; 2010 Feb; 112(2):127-30. PubMed ID: 19969413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depressive symptoms and coping in newly diagnosed patients with multiple sclerosis.
    Lode K; Bru E; Klevan G; Myhr KM; Nyland H; Larsen JP
    Mult Scler; 2009 May; 15(5):638-43. PubMed ID: 19299438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The connection between coping mechanisms, depression, anxiety and fatigue in multiple sclerosis.
    Brajković L; Bras M; Milunović V; Busić I; Boban M; Loncar Z; Micković V; Gregurek R
    Coll Antropol; 2009 Dec; 33 Suppl 2():135-40. PubMed ID: 20120530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Family caregiver quality of life in multiple sclerosis among Kuwaitis: a controlled study.
    Alshubaili AF; Ohaeri JU; Awadalla AW; Mabrouk AA
    BMC Health Serv Res; 2008 Oct; 8():206. PubMed ID: 18840287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial morbidity of Graves' orbitopathy.
    Kahaly GJ; Petrak F; Hardt J; Pitz S; Egle UT
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):395-402. PubMed ID: 16181231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do health causal attributions and coping strategies act as moderators of quality of life in peritoneal dialysis patients?
    Pucheu S; Consoli SM; D'Auzac C; Français P; Issad B
    J Psychosom Res; 2004 Mar; 56(3):317-22. PubMed ID: 15046969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relevance of anxiety, depression, and coping in patients after liver transplantation.
    Nickel R; Wunsch A; Egle UT; Lohse AW; Otto G
    Liver Transpl; 2002 Jan; 8(1):63-71. PubMed ID: 11799488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study.
    Pöhlau D; Przuntek H; Sailer M; Bethke F; Koehler J; König N; Heesen C; Späth P; Andresen I
    Mult Scler; 2007 Nov; 13(9):1107-17. PubMed ID: 17623736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [French validation of the Multiple Sclerosis International Quality of Life Questionnaire].
    Baumstarck-Barrau K; Pelletier J; Simeoni MC; Auquier P;
    Rev Neurol (Paris); 2011; 167(6-7):511-21. PubMed ID: 21420136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of depression with disease course in multiple sclerosis.
    Zabad RK; Patten SB; Metz LM
    Neurology; 2005 Jan; 64(2):359-60. PubMed ID: 15668442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Personality features in multiple sclerosis patients with a relapsing-remitting course of the disease].
    Papuć E; Pawłowska B
    Psychiatr Pol; 2005; 39(4):669-78. PubMed ID: 16237972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functionality or aesthetics? A pilot study of music therapy in the treatment of multiple sclerosis patients.
    Aldridge D; Schmid W; Kaeder M; Schmidt C; Ostermann T
    Complement Ther Med; 2005 Mar; 13(1):25-33. PubMed ID: 15907675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in quality of life and coping among people with multiple sclerosis over a 2 year period.
    McCabe MP; Stokes M; McDonald E
    Psychol Health Med; 2009 Jan; 14(1):86-96. PubMed ID: 19085315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in multiple sclerosis: a Kuwaiti MSQOL-54 experience.
    Alshubaili AF; Ohaeri JU; Awadalla AW; Mabrouk AA
    Acta Neurol Scand; 2008 Jun; 117(6):384-92. PubMed ID: 18028242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coping strategy and anxiety evolution in multiple sclerosis patients initiating interferon-beta treatment.
    Moreau T; Schmidt N; Joyeux O; Bungener C; Souvignet V
    Eur Neurol; 2009; 62(2):79-85. PubMed ID: 19521082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.